Human Serum Albumin/interferon alpha2b fusion protein(SinoBiotech)

N/A

Report date: 2026/03/15 20:00:14

Base Information

Drug NameHuman Serum Albumin/interferon alpha2b fusion protein(SinoBiotech)
Drug Alias NameAlbinterferon alfa 2B(SinoBiotech)Albumin interferon alpha2b fusion protein(SinoBiotech)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesTianjin Sinobiotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTianjin Sinobiotech Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A